Thus, submucosal EGC–derived GSNO may contribute to intestinal barrier dysfunction in IBS-D by downregulating occludin and ZO-1 expressions and cause worsening of symptoms, including visceral hypersensitivity, anxiety, and diarrhea. Here, TJP1 is linked to Anxiety.